Experiences of Clients in Three Types of Methadone Maintenance Therapy in an Atlantic Canadian City: A Qualitative Study

Abstract

Background

Methadone maintenance therapy remains the most common form of substitution therapy for opioid use disorder in Canada. Effectiveness of methadone maintenance therapy has been established, but recently newer treatment delivery models have emerged. Differences across these treatment models have not been examined.

Purpose

This descriptive qualitative study used semi-structured interviews to assess client experiences in three methadone maintenance therapy treatment delivery models: (a) comprehensive programs, (b) low-threshold/high-tolerance programs, and (c) fee-for-service programs.

Methods

A total of 32 participants were recruited from methadone maintenance therapy clinics in an Atlantic Canadian city and grouped into three models of care (n_a = 9, n_b = 11, n_c = 12). Content analysis was performed on interview data to assess the frequency of relevant themes in the data.

Results

Participants from all groups stressed the importance of supportive staff and having access to some form of counselling. However, low-threshold/high-tolerance and fee-for-service clients voiced a need for more formal counselling and programming at their clinics. Methadone was reported as the most helpful aspect of the methadone maintenance therapy programs; however, participants also expressed negative views about the substance.

Conclusions

These findings have important implications for the development and implementation of methadone maintenance therapy, specifically pertaining to further integration of addiction and mental health services.

Keywords

methadone maintenance therapy methadone treatment methadone clients qualitative research

Get full access to this article

View all access options for this article.

References

Amato

Davoli

M. A.

Perucci

Ferri

Faggiano

Mattick

R. P.

(2005). An overview of systematic reviews of the effectiveness of opioid maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28(4), 321–329. https://dx.doi.org/10.1016/j.jsat.2005.02.007

Bart

(2012). Maintenance medication for opiate addiction: The foundation of recovery. Journal of Addictive Diseases, 31(3), 207–225. http://doi.org/10.1080/10550887.2012.694598

Bruneau

Ahamad

Goyer

M. E.

Poulin

Selby

Fischer

Wild

Wood

(2018). Management of opioid use disorders: A national clinical practice guideline. Canadian Medical Association Journal, 190(9), E247–E257. http://doi.org/10.1503/cmaj.170958

Buckingham

Frings

Albery

(2013). Group membership and social identity in addiction recovery. Psychology of Addictive Behaviors, 27(4), 1132–1140. http://doi.org/10.1037/a0032480

Burbridge

A. M.

(2012). Evaluating methadone maintenance treatment outcomes in an Atlantic Canadian milieu [Unpublished doctoral dissertation]. University of New Brunswick.

Canadian Institute for Health Information. (2018). Opioid-related harms in Canada. https://www.cihi.ca/sites/default/files/document/opioid-related-harms-report-2018-en-web.pdf

Canadian Mental Health Association. (2018). Mental health in the balance: Ending the health care disparity in Canada. https://cmha.ca/news/ending-health-care-disparity-canada

Christie

T. K. S.

Murugesan

Manzer

O’Shaughnessey

M. V.

Webster

(2013). Evaluation of a low-threshold/high-tolerance methadone maintenance treatment clinic in Saint John, New Brunswick, Canada: One year retention rate and illicit drug use. Journal of Addiction, 2013, 753409. http://doi.org/10.1155/2013/753409

Connery

H. S.

(2015). Medication-assisted treatment of opioid use disorder: Review of the evidence and future direction. Harvard Review, 23(2), 63–75. http://doi.org/10.1097/HRP.00000000000000075

10.

Day

Copello

Karia

Roche

Grewal

George

Haque

Chohan

(2013). Social network support for individuals receiving opiate substitution treatment and its association with treatment progress. European Addiction Research, 19, 211–221. http://doi.org/10.1159/000343827

11.

Damon

Small

Anderson

Maher

Wood

Kerr

McNeil

(2017). Crisis’ and ‘everyday’ initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation. Drug and Alcohol Review, 36, 253–260. http://doi.org/10.1111/dar.12411

12.

Đào

Brunelle

Speed

(2019). Impact of substance use and mental health comorbidity on health care access in Canada. Journal of Dual Diagnosis, 15(4), 260–269. https://doi.org/10.1080/15504263.2019.1634856

13.

Dingle

G. A.

Stark

Cruwys

Best

(2015). Breaking good: Breaking ties with social groups may be good for recovery from substance misuse. British Journal of Social Psychology, 54, 236–254. http://doi.org/10.1111/bjso.12081

14.

Dugosh

Abraham

Seymour

McLoyd

Chalk

Festinger

(2016). A systematic review on the use of psychosocial interventions in conjunction with medication for the treatment of opioid addiction. Journal of Addiction Medicine, 10(2), 91–101. http://doi.org/10.1097/ADM.0000000000000193

15.

Dutra

Stathopoulou

Basden

S. L.

Leyro

T. M.

Powers

M. B.

Otto

M. W.

(2008). A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry, 165, 179–187. http://doi.org/10.1176/appi.ajp.2007.06111851

16.

Earnshaw

Smith

Copenhaver

(2013). Drug addiction stigma in the context of methadone maintenance therapy: An investigation into understudied sources of stigma. International Journal of Mental Health and Addiction, 11, 110–122. http://doi.org/10.1007/s11469-012-9402-5

17.

Eibl

Morin

Leinonen

Marsh

D. C.

(2017). The state of opioid agonist therapy in Canada 20 years after federal oversight. The Canadian Journal of Psychiatry, 62(7), 444–450. http://doi.org/10.1177/0706743717711167

18.

Fischer

Murphy

Rudzinski

MacPherson

(2016). Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000. International Journal of Drug Policy, 27, 23–35. http://doi.org/10.1016/j.drugpo.2015.08.007

19.

Fischer

Varatharajan

Shield

Rehm

Jones

(2018). Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada. Drug and Alcohol Dependence, 189, 76–79. http://doi.org/10.1016/j.drugalcdep.2018.04.024

20.

Gomes

Mastorakos

Paterson

J. M.

Sketris

Caetano

Greaves

Henry

(2017). Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-lasting oxycodone: A times series analysis. CMJA Open, 5(4), E800–E807. http://doi.org/10.9778/cmjao.20170104

21.

Health Canada. (2014). Canadian alcohol and drug use monitoring survey (CADUMS): Summary of results for 2012 . https://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/summary-sommaire-eng.php

22.

Hser

Evans

Grella

Ling

Anglin

(2015). Long-term course of opioid addiction. Harvard Review of Psychiatry, 23(2), 76–89. http://doi.org/10.1097/HRP.0000000000000052

23.

Kennedy

M. C.

Kerr

DeBeck

Dong

Milloy

M. J.

Wood

Hayashi

(2016). Seeking prescription opioids from physicians for nonmedical use among people who inject drugs in a Canadian setting. The American Journal on Addictions, 25(4), 1–8. http://doi.org/10.1111/ajad.12380

24.

Kourounis

Richards

B. D. W.

Kyprianou

Symeonidou

Malliori

Samartzis

(2016). Opioid substitution therapy: Lowering the treatment thresholds. Drug and Alcohol Dependence, 161, 1–8. http://doi.org/10.1016/j.drugalcdep.2015.12.021

25.

MacNeill

Brunelle

DiTommaso

Skelding

(2019). Client characteristics and substance use patterns in different models of methadone maintenance therapy (MMT). Journal of Substance Use. https://doi.org/10.1080/14659891.2019.1704083

26.

Maina

Tahir

Docabo

Kahia

Brunelle

(2019). Exploring health-care providers’ experiences in the care of clients on opioid agonist treatment in two western Canadian clinics. Canadian Journal of Nursing Research, 52(1), 15–24. https://doi.org.10.1177/0844562119842751

27.

McNeil

Kerr

Pauly

Wood

Small

(2015). Advancing patient centered care for structurally vulnerable drug-using populations: A qualitative study if the perspectives of people who use drugs regarding the potential of harm reduction interventions into hospitals. Addiction, 111, 685–694. http://doi.org/10.1111/add.13214

28.

Miller

W. R.

Moyers

T. B.

(2014). The forest and the trees: Relational and specific factors in addiction treatment. Addiction, 110, 401–413. http://doi.org/10.1111/add.12693

29.

Morrison

K. B.

Brunelle

Campbell

M. A.

Christie

T. K. S.

Hildebrand

(2017). Diversity in the needs and outcomes of low threshold/high tolerance methadone maintenance therapy clients. Canadian Journal of Addiction, 8(2), 26–33. http://doi.org/10.1097/CXA.0000000000000002

30.

New Brunswick Addiction Services. (2009). Methadone maintenance treatment: Policies and procedures . Fredericton.

31.

Paquette

C. E.

Syversten

J. L.

Pollini

R. A.

(2018). Stigma at every turn: Health services experiences among people who inject drugs. International Journal of Drug Policy, 57, 104–110. http://doi.org/10.1016/j.drugpo.2018.04.004

32.

Press

K. R.

Zornberg

G. Z.

Geller

Carrese

Fingerhood

M. I.

(2016). What patients with addiction disorders need from their primary care physicians: A qualitative study. Substance Abuse, 37(2), 349–355. http://doi.org/10.1080/08897077.2015.1080785

33.

Statistics Canada. (2017). Canadian alcohol tobacco and drugs: 2015 summary. https://www.canada.ca/en/health-canada/services/canadian-tobacco-alcohol-drugs-survey/2015-summary.html

34.

Van den Brink

Hassen

(2006). Evidence-based treatment of opioid dependent patients. Canadian Journal of Psychiatry, 51(10), 635–648. http://doi.org/10.1177/070674370605101003

35.

Veilleux

J. C.

Colvin

P. J.

Anderson

York

Heinz

A. J.

(2012). A review of opioid dependence treatments: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review, 30, 155–166. http://doi.org/10.1016/j.cpr.2009.10.006

36.

Viswanath

Chand

Benegal

Murthy

(2012). Agonist treatment in opioid use: Advances and controversy. Asian Journal of Psychiatry, 5, 125–131. http://doi.org/10.1016/j.ajp.2012.01.004

37.

Woo

Bhalerao

Bawor

Bhatt

Dennis

Mouravska

, Zielinski, L., & Samaan

(2017). “Don’t judge a book by its cover”: A qualitative study of methadone patients’ experiences of stigma. Substance Abuse: Research and Treatment, 1(12), 1178221816685087. http://doi.org/10.1177/1178221816685087